Oral tolerance, an active immunologic process mediated by multiple mechanisms.
作者信息
Weiner H L
机构信息
Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115-5817, USA.
出版信息
J Clin Invest. 2000 Oct;106(8):935-7. doi: 10.1172/JCI11348.
Abstract
摘要
相似文献
1
Oral tolerance, an active immunologic process mediated by multiple mechanisms.
J Clin Invest. 2000 Oct;106(8):935-7. doi: 10.1172/JCI11348.
2
Treatment of autoimmune diseases by oral tolerance to autoantigens.
Adv Exp Med Biol. 1995;371B:1217-23.
3
Oral tolerance in myelin basic protein TCR transgenic mice.
Ann N Y Acad Sci. 1996 Feb 13;778:412-3. doi: 10.1111/j.1749-6632.1996.tb21159.x.
4
The development of rational strategies for selective immunotherapy against autoimmune demyelinating disease.
Adv Immunol. 1991;49:357-79. doi: 10.1016/s0065-2776(08)60779-8.
5
Antigen-specific TGF-beta1 secretion with bovine myelin oral tolerization in multiple sclerosis.
Ann N Y Acad Sci. 1996 Feb 13;778:251-7. doi: 10.1111/j.1749-6632.1996.tb21133.x.
6
Designing rational therapies for multiple sclerosis.
Biotechnology (N Y). 1995 Feb;13(2):118-20. doi: 10.1038/nbt0295-118.
7
Oral tolerance in experimental autoimmune encephalomyelitis: specificity of peptide-induced oral tolerance.
Ann N Y Acad Sci. 1996 Feb 13;778:393-4. doi: 10.1111/j.1749-6632.1996.tb21154.x.
8
Oral tolerance in experimental autoimmune encephalomyelitis.
Ann N Y Acad Sci. 1996 Feb 13;778:217-27. doi: 10.1111/j.1749-6632.1996.tb21130.x.
9
Oral tolerance in autoimmune encephalomyelitis. In vivo reversal of anergy.
Ann N Y Acad Sci. 1996 Feb 13;778:382-3. doi: 10.1111/j.1749-6632.1996.tb21150.x.
10
Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies.
Crit Rev Immunol. 1997;17(1):33-75. doi: 10.1615/critrevimmunol.v17.i1.20.
引用本文的文献
1
Soybean -Conglycinin Inhibits Broiler Growth and Nutrient Utilization by Inducing Allergic and Inflammatory Responses, Impairing Intestinal Barrier Integrity and Altering Cecal Microbiota.
Animals (Basel). 2025 Jun 9;15(12):1701. doi: 10.3390/ani15121701.
2
Commensal microbiome and gastrointestinal mucosal immunity: Harmony and conflict with our closest neighbor.
Immun Inflamm Dis. 2024 Jul;12(7):e1316. doi: 10.1002/iid3.1316.
3
Insights on the role of anti-inflammatory and immunosuppressive agents in the amelioration of diabetes.
Diabetol Int. 2022 Nov 17;14(2):134-144. doi: 10.1007/s13340-022-00607-9. eCollection 2023 Apr.
4
Phosphatidylserine-mediated oral tolerance.
Cell Immunol. 2023 Feb;384:104660. doi: 10.1016/j.cellimm.2022.104660. Epub 2022 Dec 24.
5
Orally administered antigen can reduce or exacerbate pathology in an animal model of inflammatory arthritis dependent upon the timing of administration.
Immunother Adv. 2022 Sep 13;2(1):ltac020. doi: 10.1093/immadv/ltac020. eCollection 2022.
6
Rational design of a nanoparticle platform for oral prophylactic immunotherapy to prevent immunogenicity of therapeutic proteins.
Sci Rep. 2021 Sep 8;11(1):17853. doi: 10.1038/s41598-021-97333-0.
7
Roles of Macrophages in the Development and Treatment of Gut Inflammation.
Front Cell Dev Biol. 2021 Mar 2;9:625423. doi: 10.3389/fcell.2021.625423. eCollection 2021.
8
Infant Formula Supplemented with Biotics: Current Knowledge and Future Perspectives.
Nutrients. 2020 Jun 30;12(7):1952. doi: 10.3390/nu12071952.
9
Intestinal Delivery of Proinsulin and IL-10 via Combined With Low-Dose Anti-CD3 Restores Tolerance Outside the Window of Acute Type 1 Diabetes Diagnosis.
Front Immunol. 2020 Jun 9;11:1103. doi: 10.3389/fimmu.2020.01103. eCollection 2020.
10
Prebiotics in the Infant Microbiome: The Past, Present, and Future.
Pediatr Gastroenterol Hepatol Nutr. 2020 Jan;23(1):1-14. doi: 10.5223/pghn.2020.23.1.1. Epub 2020 Jan 9.
本文引用的文献
1
The regulation of immune responses to dietary protein antigens.
Immunol Today. 1987;8(3):93-8. doi: 10.1016/0167-5699(87)90853-X.
2
Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice.
Circulation. 2002 Sep 24;106(13):1708-15. doi: 10.1161/01.cir.0000029750.99462.30.
3
T-cell activation and receptor downmodulation precede deletion induced by mucosally administered antigen.
J Clin Invest. 2000 Oct;106(8):1031-8. doi: 10.1172/JCI10738.
4
Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease.
Ann Neurol. 2000 Oct;48(4):567-79.
5
Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific.
J Immunol. 2000 Jan 1;164(1):183-90. doi: 10.4049/jimmunol.164.1.183.
6
Anergy and suppression regulate CD4(+) T cell responses to a self peptide.
Eur J Immunol. 2000 Jan;30(1):136-44. doi: 10.1002/1521-4141(200001)30:1<136::AID-IMMU136>3.0.CO;2-0.
7
Oral tolerance: mechanisms and therapeutic applications.
Adv Immunol. 1999;73:153-264. doi: 10.1016/s0065-2776(08)60787-7.
8
Immunomodulation of experimental autoimmune encephalomyelitis by oral administration of copolymer 1.
Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3842-7. doi: 10.1073/pnas.96.7.3842.
9
Oral tolerance with copolymer 1 for the treatment of multiple sclerosis.
Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3333-5. doi: 10.1073/pnas.96.7.3333.
10
Anergic T cells actively suppress T cell responses via the antigen-presenting cell.
Eur J Immunol. 1998 Sep;28(9):2902-12. doi: 10.1002/(SICI)1521-4141(199809)28:09<2902::AID-IMMU2902>3.0.CO;2-B.
Zotero 插件